Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

International Stem Cell Corp $ISCO Appears To Be Breaking Out From Downtrend

|Includes: International Stem Cell Corp. (ISCO)

International Stem Cell Corp $ISCO appears to be breaking out of their long term downtrend.

They are a stem cell company based in Carlsbad CA. ISCO seems to have conquered the huge problem of immune rejection with their stem cell technology called parthenogenesis.

From company website:

Parthenogenesis (parthenos meaning "virgin" and genesis meaning "birth") utilizes unfertilized human eggs to create parthenogenetic stem cells (hpSC) that can be immune-matched to millions of persons of differing sexes and racial backgrounds. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover large parts of the world's population.

ISCO's scientists are focused on using hpSC to treat severe diseases of the eye, the nervous system and the liver where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells.

They've also created a number of non embryonic stem cell lines for research and/or commercial use. It appears that they may end up being a major supplier in the industry. This is a great revenue source.

From company website:

UniStemCell bank is the life science industry's first collection of non-embryonic histocompatible human stem cells available for research and commercial use. International Stem Cell Corporation has developed a proprietary technique for creating histocompatible stem cells. The process called parthenogenesis uses unfertilized human eggs and results in the cells inheriting a duplicate set of human leukocyte antigen (HLA) genes. This significantly reduces the possibility of the derived cells being rejected by an individual's immune system making a single cell line suitable for treating millions of individuals. A relatively small number of such cell lines could be sufficient to provide "immune matched" cells to a large percentage of the world's population.

They are currently working on multiple therapeutic areas.

In addition to their stem cell lines, they are working on treatments for Parkinsons, liver disease, and blindness due to corneal issues.

They even have a skin care line which generates additional income.

The business model they are using involves breaking various areas into subsidiaries. They are Lifeline Cell Technology (LCT), Lifeline Skin Care (NYSEARCA:LSC), and the Stem Cell Bank.

Their Stem Cell Bank should end up being a huge revenue maker in the long run. International Stem Cell Corp should end up being one of the largest of the stem cell companies. Consider this one as an addition to your long term holds.

Disclosure: I am long OTCQB:ISCO.